Magnes, denovoMATRIX, Bionomous, Sleepiz, and Sedimentum pitched their ventures at the HEMEX incubator to an online group of renowned international investors.
Collaboration Funding Innovation Press Release Regulatory
Revolutionising biomedical data sharing and AI-driven healthcare solutions
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Investment Press Release
hemotune makes a significant step forward: advancing into clinical trials after completing CHF 14 million Series B2 round
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Diversity Hemex Team
We welcome David to the team!
HEMEX contribution for preparing tomorrow's leaders!
Continue reading
Investment Press Release
Driving the future of non-surgical endometriosis diagnosis: Hera Biotech acquires Scailyte’s endometriosis diagnostic assets
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Hemex Team
Graphic Design Internship at HEMEX
Noémie is a student at FMS Muttenz. She completed a two-week internship at HEMEX focusing [...]
Continue reading
Community commitment should be something essential in every company that wants to make a difference in society. Here’s our suggestion to how you can help your community in Liestal Hemex supports educational programs with a long-term positive impact. The SOL School for Open Learning emerged from the Freie Volksschule Basel (FVB). It was founded […]
BioReperia has recently joined an international consortium of 10 partners under the umbrella of the H2020-MSCA-RISE program. We are delighted to announce that our portfolio company BioReperia has taken part in an international consortium of 10 partners under the umbrella of the H2020-MSCA-RISE program. RISE program connects organizations from the academic and non-academic sectors […]
About 1,000,000 patients undergo highly invasive heart bypass surgery yearly. Our portfolio company AMT Medical has developed a unique technology to enable a safe, affordable, and minimally invasive coronary bypass surgery. Every single day, millions of people suffer from Coronary Artery Disease (CAD). As the name suggests, it is a disease of coronary arteries, […]
Following up on our diversity series, this time we would like you to meet two of our newest additions to the team, Yaozi and Mohamed. Two energetic young people who are always looking for new challenges. Would you like to know a little more about their lives and how they just ended up at HEMEX? […]
Outstanding swiss and international start-ups and SME’s presented yesterday their business projects at the 2nd round of the Swiss Innovation Challenge. The Swiss Innovation Challenge (SIC) is an innovation promotion program in which 25 finalists and one winner are selected from over 100 innovation projects in three elimination rounds. The participants in the […]